Evidence map›Paper›PMID 39597087›Full record

ArticleMedicina (Kaunas, Lithuania)2024

Meda Marija Kaušylaitė, Justina Jurevičė, Erika Korobeinikova, Jurgita Gudaitienė, Elona Juozaitytė, Rasa Ugenskienė

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. ExploringReports of biochemistry & molecular biology · 2025
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Meda Marija KaušylaitėDepartment of Genetics and Molecular Medicine, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania.ORCID 0009-0002-4206-2042
Justina JurevičėOncology Research Laboratory, Institute of Oncology, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania.
Erika KorobeinikovaInstitute of Oncology, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania.
Jurgita GudaitienėInstitute of Oncology, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania.
Elona JuozaitytėInstitute of Oncology, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania.
Rasa UgenskienėDepartment of Genetics and Molecular Medicine, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Breast NeoplasmsDNA (Cytosine-5-)-Methyltransferase 1DNA Methyltransferase 3AAdultAgedDNA (Cytosine-5-)-MethyltransferasesFemaleGenotypeHumansLithuaniaMiddle AgedPhenotypePolymorphism, Single NucleotidePrognosisSurvival AnalysisDNA (Cytosine-5-)-Methyltransferase 1DNA (Cytosine-5-)-MethyltransferasesDNA Methyltransferase 3ADNMT1 protein, humanDNMT3A protein, humanassociationsbreast cancerDNMT1DNMT3Aphenotypepolymorphismsprognosissurvival

Identifiers

PMID39597087
PMCPMC11596321

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.